Emer Leahy

CIK: 0001875180

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

INTS

INTENSITY THERAPEUTICS, INC.

Director

KTTA

Pasithea Therapeutics Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

INTS
INTENSITY THERAPEUTICS, INC.
Jul 16, 2026
Award(A)
Stock Option (right to buy Common Stock)
Direct
5.5K shares-
KTTA
Pasithea Therapeutics Corp.
May 1, 2026
Award(A)
Stock Option (right to buy)
Direct
152.8K shares-
KTTA
Pasithea Therapeutics Corp.
Nov 28, 2025
Award(A)
Direct
33.3K shares at avg. $0.75$25K
KTTA
Pasithea Therapeutics Corp.
Oct 24, 2025
Award(A)
Stock Option (right to buy)
Direct
42.9K shares-
INTS
INTENSITY THERAPEUTICS, INC.
May 2, 2025
Award(A)
Stock Option (right to buy Common Stock)
Direct
50K shares-

		Type	Shares	Price		Ownership
Jul 16, 2026	INTS INTENSITY THERAPEUTICS, INC.	Award(A) Stock Option (right to buy Common Stock)	5,500	-	-	Direct
May 1, 2026	KTTA Pasithea Therapeutics Corp.	Award(A) Stock Option (right to buy)	152,783	-	-	Direct
Nov 28, 2025	KTTA Pasithea Therapeutics Corp.	Award(A)	33,333	$0.75	$25,000	Direct
Oct 24, 2025	KTTA Pasithea Therapeutics Corp.	Award(A) Stock Option (right to buy)	42,913	-	-	Direct
May 2, 2025	INTS INTENSITY THERAPEUTICS, INC.	Award(A) Stock Option (right to buy Common Stock)	50,000	-	-	Direct

1-5 of 5 transactions

About Leahy Emer

Leahy Emer (SEC CIK 0001875180) files insider reports with the SEC as Director of INTENSITY THERAPEUTICS, INC. (INTS) and Director of Pasithea Therapeutics Corp. (KTTA).

Signal8 holds 5 ownership filings by Leahy Emer, all Form 4s, filed between May 6, 2025 and Jul 20, 2026. Those filings report 5 transactions, from May 2, 2025 to Jul 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Leahy Emer's filings is in SHELTON, CT.

Recent filings by Leahy Emer

Jul 16, 2026: Grant or award of INTS derivative securities (Form 4, code A).
May 1, 2026: Grant or award of KTTA derivative securities (Form 4, code A).
Nov 28, 2025: Grant or award of KTTA shares (Form 4, code A).
Oct 24, 2025: Grant or award of KTTA derivative securities (Form 4, code A).
May 2, 2025: Grant or award of INTS derivative securities (Form 4, code A).

Other insiders filing for INTENSITY THERAPEUTICS, INC. (INTS)

DUBIN THOMAS I H, Director
Donovan Daniel, Director
GOLDBERG MARK A, Director
Wesolowski John M, Principal Accounting Officer
Talamo Joseph, Chief Financial Officer
BENDER LEWIS H, President and CEO

How to read Form 4 transaction codes